At its monthly meeting, EMA's
https://nitter.cz/search?q=%23safety
committee recommended measures for medicines containing pseudoephedrine & agreed to request further evidence in the GLP-1 receptor agonists’ review.
More information in our meeting highlights:
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-27-30-november-2023
https://nitter.cz/search?q=%23SafetyOfMedicines
https://nitter.cz/search?q=%23PRAC

🐦🔗: https://nitter.cz/EMA_News/status/1730568563428119026#m

[2023-12-01 12:44 UTC]